Candesartan ameliorates arsenic-induced hypertensive vascular remodeling by regularizing angiotensin II and TGF-beta signaling in rats.

Khuman, Maibam Wanta

Candesartan ameliorates arsenic-induced hypertensive vascular remodeling by regularizing angiotensin II and TGF-beta signaling in rats. [electronic resource] - Toxicology Dec 2016 - 29-41 p. digital

Publication Type: Journal Article

1879-3185

10.1016/j.tox.2016.11.015 doi


Angiotensin II--metabolism
Angiotensin II Type 1 Receptor Blockers--therapeutic use
Animals
Aorta, Thoracic--pathology
Arsenic Poisoning--drug therapy
Arsenites--antagonists & inhibitors
Benzimidazoles--therapeutic use
Biphenyl Compounds
Blood Pressure--drug effects
Collagen--metabolism
Dose-Response Relationship, Drug
Fibrosis--pathology
Male
Rats
Rats, Wistar
Signal Transduction--drug effects
Smad Proteins--metabolism
Sodium Compounds--antagonists & inhibitors
Tetrazoles--therapeutic use
Transforming Growth Factor beta--metabolism
Vascular Remodeling--drug effects